Tony Thayanandan

I am a Clinical Trial Manager and Postdoctoral Researcher in Psychiatry at the University of Oxford, where I recently completed my DPhil supervised by Professors Clare Mackay and Vanessa Raymont. My doctoral research examined the consequences of single and repeated mild Traumatic Brain Injury (mTBI) on neurodegeneration, using advanced neuroimaging analytics in Alzheimer’s disease cohorts.

I am also the Trial Manager for the Deep and Frequent Phenotyping (DFP) study, the world’s most detailed investigation into preclinical Alzheimer’s disease, led by Prof. Vanessa Raymont and run from within DPUK. The study combines brain imaging, cognitive testing, retinal scans, blood biomarkers, and wearable technology to better understand early disease mechanisms in people at risk of Alzheimer’s disease.

With a strong background in clinical trial management, neuroimaging, and data analysis, I have led the planning and delivery of multi-site Phase 2–3 clinical trials in dementia and neuroscience, ensuring regulatory compliance and successful project execution. I hold an MSc in Research Methods in Clinical Psychology and a BSc in Psychology, and I am committed to advancing clinical research into traumatic brain injury and neurodegeneration.